Dermatology · Topeka, KS
NPI
1235592668
Since 2016
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2902 SW Asbury Dr, Dermatology
Topeka, KS, 66614
Phone (785) 270-0187
Groups this clinician bills Medicare through
Medicare paid, 2024
$252K
6,107 services
Medicare patients, 2024
1,303
Average age 74
Drug cost, 2024
$648K
1,431 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Adnan Kurtovic was code 17003 (destruction skin lesion), 1,676 times for 389 patients. In total Adnan Kurtovic billed 6,107 services in 55 codes, and Medicare paid $252K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 1,676 | 389 | $4.62 | $7,736 |
| 99213 Office E&M - Established | Office | 1,137 | 862 | $59.17 | $67K |
| 17000 Destruction Skin Lesion | Office | 738 | 585 | $37.47 | $28K |
| 11102 Skin Biopsy | Office | 480 | 421 | $63.46 | $30K |
| 99203 Office E&M - New | Office | 334 | 334 | $65.45 | $22K |
| 96900 Skin | Office | 308 | 26 | $16.49 | $5,080 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 249 | 235 | $11.77 | $2,930 |
| 99214 Office E&M - Established | Office | 246 | 197 | $82.30 | $20K |
| 11103 Skin Biopsy | Office | 229 | 135 | $32.58 | $7,460 |
| 99204 Office E&M - New | Office | 113 | 113 | $100.24 | $11K |
| 11104 Skin Biopsy | Office | 53 | 51 | $72.88 | $3,862 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 43 | 32 | $0.72 | $31.02 |
| 99212 Office E&M - Established | Office | 42 | 39 | $37.36 | $1,569 |
| 36415 Venipuncture Blood Collection | Office | 32 | 21 | $8.65 | $277 |
| 11602 Skin Lesion Excision | Office | 29 | 26 | $88.43 | $2,564 |
By year: 2022 $176K for 3,796 services; 2023 $196K for 4,400 services; 2024 $252K for 6,107 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 32 | 21 | $8.65 | $277 |
Medicare prescription drug claims, 2024
In 2024, the drug Adnan Kurtovic prescribed most often to Medicare patients was Triamcinolone Acetonide, with 235 prescriptions and refills. In total Adnan Kurtovic wrote 1,431 Medicare prescriptions that cost $648K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 235 | 283 | 158 | $2,927 |
| Ketoconazole Generic | 146 | 166 | 87 | $3,148 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 113 | 125 | 75 | $2,561 |
| Clobetasol Propionate Generic | 111 | 128 | 62 | $7,840 |
| Fluorouracil Generic | 76 | 84 | 72 | $5,952 |
| Doxycycline Hyclate Generic | 76 | 134 | 46 | $2,291 |
| Clindamycin Phosphate Generic | 72 | 80 | 31 | $3,241 |
| Mupirocin Generic | 51 | 51 | 43 | $362 |
| Otezla Apremilast | 45 | 45 | Under 11 | $215K |
| Imiquimod Generic | 37 | 46 | 30 | $1,325 |
| Minoxidil Generic | 33 | 97 | 11 | $353 |
| Betamethasone Dipropionate Generic | 32 | 34 | 14 | $2,071 |
| Hydrocortisone Generic | 29 | 39 | 17 | $261 |
| Gabapentin Generic | 29 | 55 | 12 | $188 |
| Fluocinonide Generic | 21 | 26 | 15 | $1,420 |
Brand drugs: 132 claims; generic drugs: 1,299 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Adnan Kurtovic were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.